Google Maps

Microsoft Exchange Online

DMARC

Office 365 Mail

Microsoft Azure DNS

Google Maps API

Hubspot Hosted

Google Maps for Work

Chief Financial Officer, Sofinnova Partners

Christophe Blanche

Board Member & Cofounder

Martin Rothman

Financial Director

Bernard Ross

Director of Finance

Thomas Paul

Finance and Administration

Ahmed Fourati

Operations

Chris Humphrey

Events and Community Manager

Pam Putz

Venture Partner

Andrew Weiss

Head of Operations and Project Office

Anne-Sophie Castaigne

Engineering

Caroline Patard

Antoine Papiernik

Neil Mehta

Lamia Idrissi

Dominique Verdier

Lukas Guenther

Lucia Faccio

Partner, Sofinnova Telethon Fund

Anne Osdoit

Partner

Jacques Theurillat

Partner, Crossover fund

Guillaume Baxter

Senior Associate

Denis Lucquin

Managing Partner

Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.

Abivax develops medicines that alter the body's natural immune system mechanisms.

Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.

LimFlow SA is a venture-backed medical device company.

ReCor Medical has developed a unique therapeutic non-focused ultrasound system

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Investors Active in Midwestern US

Seed Stage Investors with Investments in Northeastern US

Late Stage Venture Investors with Investments in New England

European Union (EU) Seed Stage Investors

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.

The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact its collective future. It invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations with a focus on Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. They sit on the boards of their portfolio companies and play an active role from the formation phase alongside entrepreneurs.

It was headquartered in Paris, Ile-de-France in 1972.

Apollo

Private Equity Round - Sofinnova Partners

Sofinnova Digital Medicine I

Sofinnova Venture Partners XI Flagship Fund

Sofinnova Digital Medicine Venture Fund

Sofinnova Industrial Biotech II

Sofinnova Capital X

Sofinnova Crossover Fund

Sofinnova Capital IX

MD Start III

Sofinnova Telethon

Sofinnova Crossover I

Paris

Ile-de-France

France

Europe

Sofinnova Partners

European Agri-Tech Company Elicit Plant Secures $48M in Series B to Bankroll US Expansion

BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations

Cure51 launches NHS-approved study with Cambridge University Hospitals and seven other leading UK oncology institutions to unlock cancer survival secrets

Elicit Plant Announces $48 Million B Series Fundraising to accelerate global expansion and combat climate change

Elicit Plant Announces €45 Million Investment Round to Accelerate Global Expansion

Elicit Plant Raises $48M in Series B Funding

United States

North America

India

Asia

Bangladesh

United Kingdom

Sofinnova Partners is a venture capital firm that focuses on breakthrough innovations in the biotech sector, with a commitment to creating a better future for people and the planet. The company has a strong emphasis on nurturing long-term partnerships with passionate entrepreneurs and investing in companies that bring products to patients, ultimately translating into financial return.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 6, 2024 11:27 PM	b3695199
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 6, 2024 11:27 PM	c784c303
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	56c418b6
crunchbase profile	general	Nov 22, 2024 8:27 AM	eb60f848
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 8:34 AM	722d8f52
peers	general
news basic	general	Mar 6, 2024 11:27 PM	f7865796
bundesanzeiger	filings
financials download nd	financials
private financials	financials

SOFI

COM:SOFINNOVAPARTNERS

Sofinnova Partners